NeuroPace to Report Second Quarter 2024 Financial Results on August 13, 2024
NeuroPace (Nasdaq: NPCE), a medical device company specializing in epilepsy treatment, has announced its plans to release second quarter 2024 financial results on August 13, 2024, after market close. The company will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day to discuss the results.
Investors can access the live webcast at https://viavid.webcasts.com/starthere.jsp?ei=1677457&tp_key=a97b4f856d or join via telephone by dialing +1-877-407-3982 (Conference ID: 13747326). The webcast will be archived on NeuroPace's investor relations website for at least 90 days after the event.
NeuroPace (Nasdaq: NPCE), un'azienda di dispositivi medici specializzata nel trattamento dell'epilessia, ha annunciato i suoi piani per rilasciare i risultati finanziari del secondo trimestre 2024 il 13 agosto 2024, dopo la chiusura del mercato. L'azienda ospiterà una conferenza telefonica e un webcast alle 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time dello stesso giorno per discutere i risultati.
Gli investitori possono accedere al webcast live su https://viavid.webcasts.com/starthere.jsp?ei=1677457&tp_key=a97b4f856d o partecipare via telefono componendo il numero +1-877-407-3982 (ID Conferenza: 13747326). Il webcast sarà archiviato sul sito web delle relazioni con gli investitori di NeuroPace per almeno 90 giorni dopo l'evento.
NeuroPace (Nasdaq: NPCE), una empresa de dispositivos médicos especializada en el tratamiento de la epilepsia, ha anunciado sus planes para publicar los resultados financieros del segundo trimestre de 2024 el 13 de agosto de 2024, después del cierre del mercado. La empresa llevará a cabo una conferencia telefónica y un webcast a las 1:30 p.m. hora del Pacífico / 4:30 p.m. hora del Este en el mismo día para discutir los resultados.
Los inversores pueden acceder al webcast en vivo en https://viavid.webcasts.com/starthere.jsp?ei=1677457&tp_key=a97b4f856d o unirse por teléfono marcando +1-877-407-3982 (ID de Conferencia: 13747326). El webcast será archivado en el sitio web de relaciones con inversores de NeuroPace durante al menos 90 días después del evento.
NeuroPace (Nasdaq: NPCE), 간질 치료에 전문화된 의료 기기 회사는 2024년 2분기 재무 결과를 2024년 8월 13일 시장 마감 후 발표할 계획을 발표했습니다. 회사는 같은 날 오후 1:30 태평양 시간 / 오후 4:30 동부 시간에 결과를 논의하기 위한 전화 회의 및 웹캐스트를 개최할 예정입니다.
투자자는 https://viavid.webcasts.com/starthere.jsp?ei=1677457&tp_key=a97b4f856d 에서 실시간 웹캐스트에 접근하거나 +1-877-407-3982로 전화하여 참여할 수 있습니다 (회의 ID: 13747326). 웹캐스트는 이벤트 후 최소 90일 동안 NeuroPace의 투자자 관계 웹사이트에 보관될 것입니다.
NeuroPace (Nasdaq: NPCE), une société de dispositifs médicaux spécialisée dans le traitement de l'épilepsie, a annoncé ses plans de publier les résultats financiers du deuxième trimestre 2024 le 13 août 2024, après la fermeture du marché. La société tiendra un appel conférence et un webinaire à 13h30 heure du Pacifique / 16h30 heure de l'Est le même jour pour discuter des résultats.
Les investisseurs peuvent accéder au webinaire en direct sur https://viavid.webcasts.com/starthere.jsp?ei=1677457&tp_key=a97b4f856d ou rejoindre par téléphone en composant le +1-877-407-3982 (ID de conférence : 13747326). Le webinaire sera archivé sur le site de relations avec les investisseurs de NeuroPace pendant au moins 90 jours après l'événement.
NeuroPace (Nasdaq: NPCE), ein Medizintechnikunternehmen, das sich auf die Behandlung von Epilepsie spezialisiert hat, hat seine Pläne bekannt gegeben, die finanziellen Ergebnisse des zweiten Quartals 2024 am 13. August 2024, nach Börsenschluss, zu veröffentlichen. Das Unternehmen wird am selben Tag um 1:30 p.m. pazifischer Zeit / 4:30 p.m. östlicher Zeit eine Telefonkonferenz und einen Webcast abhalten, um die Ergebnisse zu besprechen.
Investoren können auf den Live-Webcast unter https://viavid.webcasts.com/starthere.jsp?ei=1677457&tp_key=a97b4f856d zugreifen oder sich per Telefon unter +1-877-407-3982 einwählen (Konferenz-ID: 13747326). Der Webcast wird für mindestens 90 Tage nach der Veranstaltung auf der Website für Investor Relations von NeuroPace archiviert.
- None.
- None.
MOUNTAIN VIEW, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the second quarter of 2024 after market close on Tuesday, August 13, 2024. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at https://viavid.webcasts.com/starthere.jsp?ei=1677457&tp_key=a97b4f856d. Individuals interested in participating in the call via telephone may access the call by dialing +1-877-407-3982 and referencing Conference ID 13747326. The webcast will be archived on the company’s investor relations website at https://investors.neuropace.com/news-and-events/events and will be available for replay for at least 90 days after the event.
About NeuroPace, Inc.
Based in Mountain View, Calif., NeuroPace is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.
Investor Contact:
Jeremy Feffer
Managing Director
LifeSci Advisors
jfeffer@lifesciadvisors.com
FAQ
When will NeuroPace (NPCE) report its Q2 2024 financial results?
How can investors access NeuroPace's (NPCE) Q2 2024 earnings call?
What time is NeuroPace's (NPCE) Q2 2024 earnings conference call scheduled for?
Where can investors find the archived webcast of NeuroPace's (NPCE) Q2 2024 earnings call?
